{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T13:36:15Z","timestamp":1779284175342,"version":"3.51.4"},"reference-count":32,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2045,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1600-0404.2009.01229.x","type":"journal-article","created":{"date-parts":[[2010,1,25]],"date-time":"2010-01-25T08:39:28Z","timestamp":1264408768000},"page":"21-26","source":"Crossref","is-referenced-by-count":37,"title":["Immunoglobulin IgG Fc-receptor polymorphisms and HLA class II molecules in Guillain-Barr\u00e9 syndrome"],"prefix":"10.1155","volume":"122","author":[{"given":"S.","family":"Sinha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. N.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. K.","family":"Nyati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2010,1,25]]},"reference":[{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB1|cit1","first-page":"613","article-title":"Campylobacter species and Guillain-Barr\u00e9 Syndrome","volume":"51","author":"Nachamkin","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ana.410340208","article-title":"The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barr\u00e9 syndrome and in other neuroimmunological disorders","volume":"34","author":"Enders","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nri856","article-title":"Roles of Fc receptors in autoimmunity","volume":"2","author":"Takai","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1212\/WNL.54.8.1661","article-title":"IgG receptor IIA alleles determine susceptibility and severity of Guillain-Barr\u00e9 syndrome","volume":"54","author":"Van der Pol","year":"2000","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1212\/WNL.55.5.705","article-title":"IgG Fc-receptor polymorphisms in Guillain-Barr\u00e9 syndrome","volume":"55","author":"Vedeler","year":"2000","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2005.01.016","article-title":"Severity of Guillain-Barr\u00e9 syndrome is associated with Fc\u03b3 receptor III polymorphisms","volume":"162","author":"Van Sorge","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1212\/01.WNL.0000148727.02732.01","article-title":"HLA class II alleles are not a general susceptibility factor in Guillain-Barr\u00e9 syndrome","volume":"64","author":"Geleijns","year":"2005","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.trstmh.2003.10.007","article-title":"Detection of preceding Campylobacter jejuni infection by polymerase chain reaction in patients with Guillain-Barr\u00e9 syndrome","volume":"98","author":"Sinha","year":"2004","journal-title":"Trans Royal Soc Trop Med Hyg"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain-Barr\u00e9 syndrome: clinical associations and outcome","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1469-0691.2006.01636.x","article-title":"Preceding infections and anti-ganglioside antibodies in patients with Guillain-Barr\u00e9 syndrome: a single center prospective case-control study","volume":"13","author":"Sinha","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"Simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1046\/j.1537-2995.2000.40111388.x","article-title":"Allelic polymorphisms of human Fc\u03b3 receptor IIa and Fc\u03b3 receptor IIIb among distinct groups in Brazil","volume":"40","author":"Kuwano","year":"2000","journal-title":"Transfusion"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1172\/JCI119616","article-title":"A novel polymorphism of Fc\u03b3RIIIA (CD16) alters receptor function and predisposes to autoimmune disease","volume":"100","author":"Wu","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1212\/WNL.52.9.1771","article-title":"Immunoglobulin G Fc-receptor (Fc\u03b3R) IIA and IIIB polymorphisms related to disability in MS","volume":"52","author":"Myhr","year":"1999","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0198-8859(00)00115-4","article-title":"MHC class I and class II phenotype, gene, and haplotype frequencies in Greeks using molecular typing data","volume":"61","author":"Papassavas","year":"2000","journal-title":"Hum Immunol"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0165-5728(93)90239-U","article-title":"Ganglioside and bacterial toxins in Guillain-Barr\u00e9 syndrome","volume":"46","author":"Williston","year":"1993","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0167-5699(97)01007-4","article-title":"Clinical significance of IgG Fc receptors and Fc\u03b3R-directed immunotherapies","volume":"18","author":"Deo","year":"1997","journal-title":"Immunol Today"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"The Dutch Guillain-Barr\u00e9 study group, A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome","volume":"326","author":"Van der Meche","year":"1992","journal-title":"N Eng J Med"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.51.6_Suppl_5.S2","article-title":"Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic disease","volume":"51","author":"Dalakas","year":"1998","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0165-5728(01)00344-7","article-title":"Fc receptors for immunoglobulin G - a role in the pathogenesis of Guillain-Barr\u00e9 syndrome and multiple sclerosis","volume":"118","author":"Vedeler","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/jnr.490310409","article-title":"Expression of genes coding receptors for IgG (FcRIII) and for C3b\/C4b (Crry) in rat sciatic nerve during development and Wallerian degeneration","volume":"31","author":"Vedeler","year":"1992","journal-title":"J Neuro Sci Res"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(97)12308-X","article-title":"Guillain Barr\u00e9 syndrome","volume":"352","author":"Hahn","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.880180202","article-title":"Immunopathogenesis and treatment of the Guillain-Barr\u00e9 syndrome","volume":"18","author":"Hartung","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00005072-199311000-00001","article-title":"Macrophages systems in peripheral nerves: a review","volume":"52","author":"Griffin","year":"1993","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB26|cit26","first-page":"696","article-title":"Preclinical studies with Fc\u03b3R bispecific antibodies and granulocyte colony stimulating factor-primed neutrophils as effector cells against HER-2\/neu over expressing breast cancer","volume":"57","author":"Stockmeyer","year":"1997","journal-title":"Cancer Res"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.4049\/jimmunol.144.4.1304","article-title":"Cross linking of both Fc\u03b3RI and Fc\u03b3RII induces secretion of tumor necrosis factor by human monocytes, requiring high affinity Fc-Fc\u03b3R interactions. Functional activation of Fc\u03b3RII by treatment with protease or neuraminidase","volume":"144","author":"Debets","year":"1990","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJM200009143431106","article-title":"The HLA system. Second of two parts","volume":"343","author":"Klein","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB29|cit29","first-page":"968","article-title":"Serotype of Campylobacter jejuni, HLA and the Guillain-Barr\u00e9 syndrome","volume":"15","author":"Yuki","year":"1992","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0165-5728(95)00102-8","article-title":"HLA-class II alleles in Guillain-Barr\u00e9 syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection","volume":"62","author":"Rees","year":"1995","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(99)91443-5","article-title":"Influence of MHC class II genotype on outcome of infection with hepatitis C virus","volume":"354","author":"Thursz","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.2009.01229.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1034\/j.1399-0039.2000.550103.x","article-title":"Association of DRB1*1501 with disseminated Mycobacterium avium complex infection in North American AIDS patients","volume":"55","author":"LeBlanc","year":"2000","journal-title":"Tissue Antigens"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.2009.01229.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.2009.01229.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T19:03:44Z","timestamp":1685387024000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.2009.01229.x"}},"subtitle":["IgG and HLA-II molecules in Guillain-Barr\u00e9 syndrome"],"short-title":[],"issued":{"date-parts":[[2010,1,25]]},"references-count":32,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.2009.01229.x","relation":{},"ISSN":["0001-6314","1600-0404"],"issn-type":[{"value":"0001-6314","type":"print"},{"value":"1600-0404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,25]]}}}